Miyauchi H, Kozuki K, Tanio T, Ohashi N
Research Center, Sumitomo Pharmaceuticals Co., Ltd., Osaka, Japan.
Chem Pharm Bull (Tokyo). 1996 Apr;44(4):785-92. doi: 10.1248/cpb.44.785.
3-Methyl and 3,3-dimethyl analogs of 2-(2,4-difluorophenyl)-3-(omega-substituted alkyl)sulfonyl-1-(1H-1,2,4-triazol-1-yl)-2-propanols were synthesized and evaluated for their antifungal activities against Candida albicans and Aspergillus fumigatus. The 3,3-dimethyl analogs were found to have more potent activity both in vitro and in vivo than the corresponding 3-mono-methyl analogs. The prophylactic efficacy of the lead compounds against murine systemic candidiasis and aspergillosis was improved significantly by dimethylation of the 3-position.